These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7955067)

  • 1. Computer program for the analysis of mutational spectra: application to p53 mutations.
    Cariello NF; Piegorsch WW; Adams WT; Skopek TR
    Carcinogenesis; 1994 Oct; 15(10):2281-5. PubMed ID: 7955067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of p53 and K-ras mutations in human lung cancer tissues.
    Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
    Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
    Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K
    Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.
    Law JC; Whiteside TL; Gollin SM; Weissfeld J; El-Ashmawy L; Srivastava S; Landreneau RJ; Johnson JT; Ferrell RE
    Clin Cancer Res; 1995 Jul; 1(7):763-8. PubMed ID: 9816043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking.
    Takagi Y; Osada H; Kuroishi T; Mitsudomi T; Kondo M; Niimi T; Saji S; Gazdar AF; Takahashi T; Minna JD; Takahashi T
    Br J Cancer; 1998 May; 77(10):1568-72. PubMed ID: 9635830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Database and software for the analysis of mutations in the human p53 gene.
    Cariello NF; Cui L; Beroud C; Soussi T
    Cancer Res; 1994 Aug; 54(16):4454-60. PubMed ID: 8044795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.
    Ahrendt SA; Chow JT; Yang SC; Wu L; Zhang MJ; Jen J; Sidransky D
    Cancer Res; 2000 Jun; 60(12):3155-9. PubMed ID: 10866304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?
    Pfeifer GP; Denissenko MF
    Environ Mol Mutagen; 1998; 31(3):197-205. PubMed ID: 9585258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.
    Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and p53 mutations in lung cancer and bladder cancer.
    Husgafvel-Pursiainen K; Kannio A
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):553-6. PubMed ID: 8781382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to understanding p53 gene tumor mutation spectra.
    Hollstein M; Hergenhahn M; Yang Q; Bartsch H; Wang ZQ; Hainaut P
    Mutat Res; 1999 Dec; 431(2):199-209. PubMed ID: 10635987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in p53 mutational status in small cell lung cancer.
    Tseng JE; Rodriguez M; Ro J; Liu D; Hong WK; Mao L
    Cancer Res; 1999 Nov; 59(22):5666-70. PubMed ID: 10582680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.
    Wu WG; Soria JC; Wang L; Kemp BL; Mao L
    Anticancer Res; 2000; 20(6B):4525-9. PubMed ID: 11205299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
    Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K
    Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.